Discussion about this post

User's avatar
Andrew Tan's avatar

The UK JCVI statement you discuss was about vaccination for ages 12-15. The JCVI recognized a benefit, so it is unlikely that the additional considerations you give would change the calculations much, particularly as it had not been demonstrated that the vaccine reduces the risk of PMIS, if infected. However, there is not necessarily a big difference between the JCVI's and your views. The JCVI recognized that there may be other considerations that strengthen the case for vaccination, and explicitly suggested the Chief Medical Officers consider those in making their final recommendation. The decision of the CMOs at that time was to make one dose of vaccine available, recognize that there should be no stigmatization of parents who choose not to vaccinate due to the fine balance of arguments, and state that the issue of a second dose should be revisited in a few months. Those decisions were before Omicron emerged. When Omicron emerged, the UK decided to give second doses for ages 12-15.

Expand full comment
Mike Doherty's avatar

Excellent post. Can you draft an essay on the efficacy of booster shots?

Expand full comment
80 more comments...

No posts